Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011.

Lee SH, Kim KH, Lee SG, Chen DH, Jung DS, Moon CS, Park JY, Chung JS, Kwak IS, Cho GJ.

J Korean Med Sci. 2013 Jan;28(1):67-73. doi: 10.3346/jkms.2013.28.1.67. Epub 2013 Jan 8.

3.

Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.

Yang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, Hung CC, Yang SY.

HIV Med. 2008 Aug;9(7):535-43. doi: 10.1111/j.1468-1293.2008.00600.x. Epub 2008 Jun 28.

4.

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.

Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, Armstrong AW, Fraser S, Wallace MR; Triservice AIDS Clinical Consortium.

J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):194-200.

PMID:
16394852
5.

Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.

Katsarou O, Touloumi G, Antoniou A, Kouramba A, Hatzakis A, Karafoulidou A.

Haemophilia. 2005 Jul;11(4):360-5.

PMID:
16011588
7.

Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.

Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK.

J Infect Dis. 2002 Oct 1;186(7):1023-7. Epub 2002 Sep 13.

PMID:
12232845
8.

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD; HIV Outpatient Study Investigators.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34.

PMID:
16878047
9.

Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000.

Jain MK, Skiest DJ, Cloud JW, Jain CL, Burns D, Berggren RE.

Clin Infect Dis. 2003 Apr 15;36(8):1030-8. Epub 2003 Apr 2.

PMID:
12684916
10.

Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.

Sánchez JM, Ramos Amador JT, Fernández de Miguel S, González Tomée MI, Rojo Conejo P, Ferrnado Vivas P, Clemente Vivas J, Ruiz Contreras J, Nogales Espert A.

Pediatr Infect Dis J. 2003 Oct;22(10):863-7.

PMID:
14551485
11.

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, Costagliola D, May T, Chêne G; Mortality 2000 study group.

Int J Epidemiol. 2005 Feb;34(1):121-30. Epub 2004 Nov 23.

PMID:
15561752
12.
13.

Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.

Viani RM, Araneta MR, Deville JG, Spector SA.

Clin Infect Dis. 2004 Sep 1;39(5):725-31. Epub 2004 Aug 16.

PMID:
15356789
14.

Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study.

Kouanda S, Meda IB, Nikiema L, Tiendrebeogo S, Doulougou B, Kaboré I, Sanou MJ, Greenwell F, Soudré R, Sondo B.

AIDS Care. 2012;24(4):478-90. doi: 10.1080/09540121.2011.630353. Epub 2011 Dec 7.

PMID:
22148973
15.

Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries.

Llibre JM, Revollo B, Vanegas S, Lopez-Nuñez JJ, Ornelas A, Marin JM, Santos JR, Marte P, Morera M, Zuluaga P, Tor J, Clotet B.

Scand J Infect Dis. 2013 Aug;45(8):635-44. doi: 10.3109/00365548.2013.777778. Epub 2013 Apr 3.

PMID:
23547568
16.

Pneumocystis jiroveci pneumonia in patients with AIDS in the inner city: a persistent and deadly opportunistic infection.

Tellez I, Barragán M, Franco-Paredes C, Petraro P, Nelson K, Del Rio C.

Am J Med Sci. 2008 Mar;335(3):192-7. doi: 10.1097/MAJ.0b013e318152004b.

PMID:
18344692
17.

Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.

Simmons RD, Ciancio BC, Kall MM, Rice BD, Delpech VC.

HIV Med. 2013 Nov;14(10):596-604. doi: 10.1111/hiv.12045. Epub 2013 May 15.

18.

Mortality and morbidity of HIV infected patients receiving HAART: a cohort study.

Panos G, Samonis G, Alexiou VG, Kavarnou GA, Charatsis G, Falagas ME.

Curr HIV Res. 2008 May;6(3):257-60.

PMID:
18473789
19.

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers.

Sabin CA, Smith CJ, Youle M, Lampe FC, Bell DR, Puradiredja D, Lipman MC, Bhagani S, Phillips AN, Johnson MA.

AIDS. 2006 Jan 2;20(1):67-71.

PMID:
16327321
20.

Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.

Palacios R, Hidalgo A, Reina C, de la Torre M, Márquez M, Santos J.

HIV Med. 2006 Apr;7(3):193-6.

Supplemental Content

Support Center